| Parameter |
PR Group (n=12) |
SR Group (n=11) |
P value |
| Mean |
Median |
Mean |
Median |
| G (K dynes/cm2) |
12.8 ± 3.22 |
12.5 [11.2, 14.2] |
9.7 ± 3.50 |
11.2 [7.6, 12.5] |
0.07 |
| TEG® MA (mm) |
71.2 ± 4.80 |
71.4 [69.1, 74.0] |
62.3 ± 11.91 |
67.8 [54.1, 71.8] |
0.06 |
| MA Activator (mm) |
18.2 ± 16.12 |
10.1 [8.8, 20.5] |
7.4 ± 6.24 |
6.3 [3.1, 7.9] |
0.01* |
| ADP MA (mm) |
58.2 ± 10.84 |
58 [49.4, 62.7] |
42.8 ± 12.07 |
47.3 [36.5, 50.8] |
0.01* |
| AA MA (mm) |
60.5 ± 15.01 |
60.4 [52.3, 71.7] |
50.6 ± 14.64 |
52 [47.7, 58.7] |
0.02* |
| ADP Inhibition (%) |
23.4 ± 12.92 |
22.7 [13.8, 32.2] |
36.6 ± 13.21 |
34.6 [28.7, 39.25] |
0.03* |
| AA Inhibition (%) |
19.6 ± 22.15 |
13.4 [8.0, 18.0] |
25.9 ± 26.07 |
20.3 [9.4, 31.1] |
0.49 |
| ADP Aggregation (%) |
0.8 ± 0.13 |
0.8 [0.7, 0.9] |
0.6 ± 0.13 |
0.7 [0.6, 0.7] |
0.03* |
| AA Aggregation (%) |
0.8 ± 0.22 |
0.9 [0.8, 1.0] |
0.7 ± 0.26 |
0.8 [0.7, 0.9] |
0.49 |
Data are presented as mean ± SD and median [1st Quartile, 3rd Quartile]. Two-tailed
P value determined using Mann-Whitney U test. SD = Standard Deviation; PR =
propofol/remifentanyl; SR = sevoflurane/remifentanyl. |
Table 3a: Preoperative TEG® PM™ Data.
This table provides the postoperative TEG® PM™ measurements for both the PR
and SR groups. These measurements include G, TEG® MA, MA Activator, ADP MA,
AA MA, ADP Inhibition, AA Inhibition, ADP Aggregation, AA Aggregation. |
